However, blocking CD47 at the peak of the disease worsens disease activity in mouse models of systemic lupus erythematosus (SLE) and experimental autoimmune encephalomyelitis (EAE) (84, 85). The gene discussed is CD47; the disease is systemic lupus erythematosus.